Picture a simple breath mint that freshens your mouth while rebuilding tooth enamel. Researchers at the University of Washington are preparing to launch the first human clinical trials for this innovative solution.
Enamel, the hardest substance in the human body, shields the visible surface of your teeth. Yet it wears down over time from vigorous brushing, acidic erosion, or grinding, exposing dentin and causing sensitivity, yellowing, or gum problems.
Whitening treatments relying on hydrogen peroxide provide cosmetic relief but can weaken enamel further with extended use. A University of Washington research team offers a game-changing alternative to regenerate this irreplaceable layer.
These lozenges feature a genetically modified peptide from amelogenin—the primary protein in enamel formation—plus calcium and phosphate ions, enamel's core components. The peptide also supports cementum on tooth roots.
Dissolving in the mouth, it deposits a micrometers-thick new enamel layer onto damaged areas, sparing soft oral tissues.
Preclinical tests on extracted human, pig, and rat teeth, plus live mice, confirm one daily lozenge maintains enamel against wear, while two rebuild it. Clinical trials are next.
“We have three goals in the clinical trial,” Professor Sarikaya explained. “First, demonstrate effectiveness. Second, documentation. Third, benchmarking—comparing whitening to commercial treatments,” noted dentist Sami Dogan, the project's pioneer. “Each study will take two weeks, with trials wrapping in three months.”
If successful, this could pioneer true enamel repair, revolutionizing dentistry for healthier smiles.
